Developer docs
API playgroundTry for free, no card

Search company profiles

Yonghua Capital

Full company profile

uuid0002hsa

Namestring
Yonghua Capital
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Yonghua Capital is a Shanghai-based private investment firm founded in 1994, operating with a headcount of 11-50 employees. The firm functions as a venture capital investor focused on early- and growth-stage opportunities in artificial intelligence and biotechnology, with recent activity concentrated in deep-tech AI applications. Its leadership team comprises co-founder and managing director Moses Zhao, executive director Li Yang, and deputy director Zhang Chen. There is no public disclosure of AUM, fund vintage, or fee structure.

The firm's recent transaction activity reveals a deliberate thematic focus at the intersection of AI and life sciences. In March 2026, Yonghua Capital led a ¥50M funding round in C12.ai, an AI robotics company developing the Talos dual-arm lab robot for pharmaceutical laboratories; C12.ai was founded in 2022 by Chen Zhigang, former Alibaba Health chief architect and WuXi AppTec's first CDO, and is backed by Yunqi Partners. In the same period, Yonghua co-led a Series A+ financing exceeding ¥200M for Tianmu Technology (天鹬科技), a Shanghai-based AI protein design service provider advancing its AccelProtein™ AI platform, alongside state-aligned co-investors China National Petroleum Kunlun Capital and Shanghai Future Industry Fund.

As a private investment firm, Yonghua Capital's revenue mechanics derive from conventional VC fund economics — management fees on committed capital and carried interest on realized returns — though none of these figures are publicly disclosed. The firm's business model relies on deal flow sourced through its leadership network, co-investor relationships with state-affiliated capital, and thematic conviction in deep-tech sectors. Customer-facing products, pricing, and go-to-market mechanics are not applicable in the traditional sense for an investment manager.

Short descriptiontext

Yonghua Capital is a Shanghai-based private venture capital firm founded in 1994 that invests in early- and growth-stage AI and biotech companies, with recent lead investments in C12.ai and Tianmu Technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
venture capital investing, early-stage funding, AI startup investments, biotech venture capital, technology equity financing
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code3 codes
  • All Other Financial Investment Activities52399
  • Other Financial Investment Activities5239
  • Miscellaneous Intermediation52391
SIC code2 codes
  • Investment Advice6282
  • Investors, Nec6799
Product category
Venture Capital
No data
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Yonghua Capital is a private venture capital investment firm that leads and co-leads early-stage funding rounds for technology startups. The firm invests in AI and biotech sectors, as evidenced by its lead investment in C12.ai (an AI robotics company) and co-led Series A+ investment in Tianmu Technology (an AI protein design company).

Differentiator
Functional benefit
Problem solved
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

China-headquartered early-stage VC investing across enterprise, consumer, and frontier tech including AI. Comparable as a Chinese VC writing Series A checks into AI-enabled startups.

TypeDirect peer
Description

Large Chinese seed and Series A investor with broad tech exposure including AI. Comparable as a Chinese early-stage VC competing for the same AI founders and co-investor syndicates.

TypeDirect peer
Description

China-focused venture firm investing in AI, robotics, and biotech at Series A and beyond. Comparable as a Chinese sector-focused VC active in AI robotics and life sciences, overlapping Yonghua's deal themes.

TypeDirect peer
Description

Shanghai-based early-stage Chinese VC with focus on deep tech, AI, and biotech. Comparable geographic and sectoral positioning to Yonghua Capital, competing for similar founder relationships in the Shanghai AI ecosystem.

TypeDirect peer
Description

Strategic/corporate venture arm of China National Petroleum. Comparable as a co-investor in Tianmu Technology and as a Chinese growth-equity player deploying capital into deep-tech and industrial tech verticals.

TypeDirect peer
Description

Chinese VC firm focused on AI, enterprise SaaS, and deep-tech. Comparable as a similarly sized Chinese sector-focused VC competing for early-stage AI deal flow.

TypeBroad incumbent
Description

One of the largest China-focused VC/PE firms with broad sector exposure including deep tech and healthcare. Comparable as a Chinese institutional VC whose portfolio intersects AI and biotech, though at materially greater scale.

TypeDirect peer
Description

China-focused tech VC founded by Kai-Fu Lee with strong AI and deep-tech specialization. Comparable as a Chinese AI-vertical VC; broader AUM but operating in the same early-to-growth AI deal pool.

TypeDirect peer
Description

China-based early-to-growth stage VC firm focused on deep tech and enterprise software. Directly comparable as a co-investor in C12.ai and as a peer Chinese deep-tech VC operating at similar check sizes.

TypeBroad incumbent
Description

Major China-focused venture and growth firm investing across AI, biotech, and consumer. Comparable incumbent operating in the same Chinese AI/biotech deal market, with materially larger AUM and broader stage coverage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment188 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Yonghua Capital

Venture Capitalyonghuacapital.com.cn

Yonghua Capital is a Shanghai-based private venture capital firm founded in 1994 that invests in early- and growth-stage AI and biotech companies, with recent lead investments in C12.ai and Tianmu Technology.

What Yonghua Capital does

Yonghua Capital is a Shanghai-based private investment firm founded in 1994, operating with a headcount of 11-50 employees. The firm functions as a venture capital investor focused on early- and growth-stage opportunities in artificial intelligence and biotechnology, with recent activity concentrated in deep-tech AI applications. Its leadership team comprises co-founder and managing director Moses Zhao, executive director Li Yang, and deputy director Zhang Chen. There is no public disclosure of AUM, fund vintage, or fee structure.

The firm's recent transaction activity reveals a deliberate thematic focus at the intersection of AI and life sciences. In March 2026, Yonghua Capital led a ¥50M funding round in C12.ai, an AI robotics company developing the Talos dual-arm lab robot for pharmaceutical laboratories; C12.ai was founded in 2022 by Chen Zhigang, former Alibaba Health chief architect and WuXi AppTec's first CDO, and is backed by Yunqi Partners. In the same period, Yonghua co-led a Series A+ financing exceeding ¥200M for Tianmu Technology (天鹬科技), a Shanghai-based AI protein design service provider advancing its AccelProtein™ AI platform, alongside state-aligned co-investors China National Petroleum Kunlun Capital and Shanghai Future Industry Fund.

As a private investment firm, Yonghua Capital's revenue mechanics derive from conventional VC fund economics — management fees on committed capital and carried interest on realized returns — though none of these figures are publicly disclosed. The firm's business model relies on deal flow sourced through its leadership network, co-investor relationships with state-affiliated capital, and thematic conviction in deep-tech sectors. Customer-facing products, pricing, and go-to-market mechanics are not applicable in the traditional sense for an investment manager.

Yonghua Capital firmographics

Firmographics
Name
Yonghua Capital
Website
https://yonghuacapital.com.cn
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
Yonghua Capital is a Shanghai-based private venture capital firm founded in 1994 that invests in early- and growth-stage AI and biotech companies, with recent lead investments in C12.ai and Tianmu Technology.
Ownership category
akta.pro rank

Yonghua Capital industry classification

Industry
Product category
Venture Capital
NAICS
All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239), Miscellaneous Intermediation (52391)
SIC
Investment Advice (6282), Investors, Nec (6799)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital investing
  • Early-stage funding
  • AI startup investments
  • Biotech venture capital
  • Technology equity financing

Where Yonghua Capital is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Markets served

Yonghua Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Yonghua Capital product offering

Product offering

Core offering

Yonghua Capital is a private venture capital investment firm that leads and co-leads early-stage funding rounds for technology startups. The firm invests in AI and biotech sectors, as evidenced by its lead investment in C12.ai (an AI robotics company) and co-led Series A+ investment in Tianmu Technology (an AI protein design company).

Differentiator

Problem solved

Functional benefit

Companies that use Yonghua Capital

Customer profile

Ideal customer profiles1 record

Yonghua Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Yonghua Capital partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Yonghua Capital competitors and assessment

Company assessment

Direct peers

  • Source Code Capital: China-headquartered early-stage VC investing across enterprise, consumer, and frontier tech including AI. Comparable as a Chinese VC writing Series A checks into AI-enabled startups.
  • ZhenFund: Large Chinese seed and Series A investor with broad tech exposure including AI. Comparable as a Chinese early-stage VC competing for the same AI founders and co-investor syndicates.
  • MSA Capital: China-focused venture firm investing in AI, robotics, and biotech at Series A and beyond. Comparable as a Chinese sector-focused VC active in AI robotics and life sciences, overlapping Yonghua's deal themes.
  • Lighthouse Capital: Shanghai-based early-stage Chinese VC with focus on deep tech, AI, and biotech. Comparable geographic and sectoral positioning to Yonghua Capital, competing for similar founder relationships in the Shanghai AI ecosystem.
  • CNPC Kunlun Capital: Strategic/corporate venture arm of China National Petroleum. Comparable as a co-investor in Tianmu Technology and as a Chinese growth-equity player deploying capital into deep-tech and industrial tech verticals.
  • Linear Venture: Chinese VC firm focused on AI, enterprise SaaS, and deep-tech. Comparable as a similarly sized Chinese sector-focused VC competing for early-stage AI deal flow.
  • Sinovation Ventures: China-focused tech VC founded by Kai-Fu Lee with strong AI and deep-tech specialization. Comparable as a Chinese AI-vertical VC; broader AUM but operating in the same early-to-growth AI deal pool.
  • Yunqi Partners: China-based early-to-growth stage VC firm focused on deep tech and enterprise software. Directly comparable as a co-investor in C12.ai and as a peer Chinese deep-tech VC operating at similar check sizes.

Broad incumbents

  • IDG Capital: One of the largest China-focused VC/PE firms with broad sector exposure including deep tech and healthcare. Comparable as a Chinese institutional VC whose portfolio intersects AI and biotech, though at materially greater scale.
  • Sequoia Capital China (HongShan): Major China-focused venture and growth firm investing across AI, biotech, and consumer. Comparable incumbent operating in the same Chinese AI/biotech deal market, with materially larger AUM and broader stage coverage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Yonghua Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Yonghua Capital leadership team

Management profile

Number of profiles

Profiles3 records

Yonghua Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Yonghua Capital M&A and investment

M&A and investment

M&A

Investments188 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yonghua Capital

What does Yonghua Capital do?

Yonghua Capital is a private venture capital investment firm that leads and co-leads early-stage funding rounds for technology startups. The firm invests in AI and biotech sectors, as evidenced by its lead investment in C12.ai (an AI robotics company) and co-led Series A+ investment in Tianmu Technology (an AI protein design company).

Is Yonghua Capital a public or private company?

Yonghua Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Yonghua Capital founded?

Yonghua Capital was founded in 1994. It employs 11 to 50 people.

Where is Yonghua Capital based?

Yonghua Capital is headquartered in Shanghai, China, in the Asia region.

Who are Yonghua Capital's main competitors?

Direct peers on record are Source Code Capital, ZhenFund, MSA Capital, Lighthouse Capital, CNPC Kunlun Capital, Linear Venture, Sinovation Ventures and Yunqi Partners. Broad incumbents are IDG Capital and Sequoia Capital China (HongShan).

Does Yonghua Capital have an API?

No public API is recorded for Yonghua Capital.

What industry is Yonghua Capital in?

Yonghua Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Fastdata极数Huzhou laser communication technology solution provider Biyi Laser has obtained hundreds of millions of RMB in Series B financing - FastdataBiyi Laser, a Huzhou laser communication technology provider, raised hundreds of millions of RMB in Series B financing led by Yonghua Investment. The company offers inter-satellite, satellite-ground, air-ground, and portable laser communication terminals, with R&D supported by Zhejiang University and Harbin Institute of Technology.36kr"Sorcero Technology" has officially completed a Series B financing round of over 100 million yuan.-36氪Shexu Technology, an industrial AI design and R&D solution provider, completed a Series B financing round of over 100 million yuan, bringing its total accumulated funding to exceed 300 million yuan. Investors include Shenchan Investment, Hedinggong, and existing shareholder Yonghua Investment. The proceeds will support market expansion, including overseas business development, and R&D of core model technologies.Jixin60 people merged 100 million, investors rush to grab upstream nuclear fusionShuyanjuchuang, a domestic fusion auxiliary systems provider, completed seed and angel rounds totaling 100 million yuan in six months. The company, led by Tsinghua alumnus Liu He, focuses on neutral beam heating and plasma diagnostics, aiming to replace imported equipment. It plans to deliver core equipment within a year and expand into semiconductors and aerospace.ChinaventureTianmu Technology completes hundreds of millions in A++ round financingTianmu Technology completed hundreds of millions in A++ financing on July 13, led by Shanghai Guotou Pioneer and Guotou Innovation. The funds will support AI technology iteration and large-scale application of protein design in circular economy, drugs, and healthcare.Fastdata极数上海AI蛋白质设计服务商天鹜科技完成数亿元A++轮融资 – Fastdata极数Tianmu Technology, an AI protein design service provider, completed a hundreds-of-millions A++ round financing. The round was led by Shanghai Guotou Xian Dao and Guotou Innovation, with participation from multiple investors. The company aims to provide full-process AI protein solutions for biomedicine and synthetic biology.PandailyMinyue Technology Secures Pre-B+ Funding Round to Expand Industrial AI Welding SystemsMinyue Technology completed a Pre-B+ funding round with Yonghua Capital, following a Pre-B round in November 2025. The funds will support R&D of embodied intelligent welding and cutting systems, data infrastructure, and international expansion. The company reports nearly 10,000 deployed units and over 100 million meters of welding data.PedailyLeading the change, empowering the future: The 2026 Jing'an Artificial Intelligence Investment Sharing Salon was successfully held.Jing'an District held the 2026 Artificial Intelligence Investment Sharing Salon, bringing together industry and capital. The event aims to integrate AI with key industries under the "(3+3)+(1+3+X)" modern industrial system. It seeks to help technology enterprises grow in Jing'an, contributing to Shanghai's global metropolis construction.Fastdata极数上海AI蛋白质设计服务商天鹜科技宣布完成超2亿元A+轮融资 – Fastdata极数Tianmu Technology, a Shanghai-based AI protein design service provider, has completed a Series A+ financing round raising over 200 million yuan. The round was led by China National Petroleum Kunlun Capital, Yonghua Investment, and Shanghai Future Industry Fund, with participation from multiple institutional investors including Guotou Investment, Farmer Capital, and Futen Capital. The company intends to use the funds to advance its AccelProtein™ AI platform, which addresses challenges in protein design including long development times, high costs, and low success rates under traditional methods.PedailyShexu Technology has received tens of millions in Pre-B round financing, with Yonghua Investment and GF Xinde jointly investing.Shexu Technology has completed a Pre-B round financing of tens of millions, with investors Yonghua Investment and GF Xinde participating, having raised over 100 million yuan across three financing rounds in the past year. The company's product 'Shanshe' is an industrial intelligent generative design software that provides 3D design solutions and 2D engineering drawings under a cloud architecture. Shexu Technology plans to use the funds for R&D and market promotion, including overseas expansion into European markets.EqualOceanMellow Energy Completes Pre-A Round FinancingGuangdong Mellow Energy Technology Co., Ltd. has completed a Pre-A financing round led by Huajin Capital, with follow-on investments from ShenZhen Startup Internet Investment Management and Yonghua Capital. The funds raised will be primarily used for the construction of a 100MW perovskite photovoltaic module production line in Zhuhai City, which is expected to begin operations in the second half of the year.